Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Post-traumatic Stress Disorder Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Antidepressants, Antipsychotics, Anti-anxiety, Others)
5.2.2. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Drug Class
5.3.2. By Distribution Channel
5.3.3. By Region
6. North America Post-traumatic Stress Disorder Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Distribution Channel
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Post-traumatic Stress Disorder Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Distribution Channel
6.3.2. Canada Post-traumatic Stress Disorder Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Distribution Channel
6.3.3. Mexico Post-traumatic Stress Disorder Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Distribution Channel
7. Europe Post-traumatic Stress Disorder Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Distribution Channel
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Post-traumatic Stress Disorder Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Distribution Channel
7.3.2. France Post-traumatic Stress Disorder Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Distribution Channel
7.3.3. United Kingdom Post-traumatic Stress Disorder Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Distribution Channel
7.3.4. Italy Post-traumatic Stress Disorder Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Distribution Channel
7.3.5. Spain Post-traumatic Stress Disorder Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Distribution Channel
8. Asia-Pacific Post-traumatic Stress Disorder Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Distribution Channel
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Post-traumatic Stress Disorder Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Distribution Channel
8.3.2. Japan Post-traumatic Stress Disorder Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Distribution Channel
8.3.3. India Post-traumatic Stress Disorder Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Distribution Channel
8.3.4. South Korea Post-traumatic Stress Disorder Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Distribution Channel
8.3.5. Australia Post-traumatic Stress Disorder Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Distribution Channel
9. South America Post-traumatic Stress Disorder Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Distribution Channel
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Post-traumatic Stress Disorder Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Distribution Channel
9.3.2. Argentina Post-traumatic Stress Disorder Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Distribution Channel
9.3.3. Colombia Post-traumatic Stress Disorder Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Distribution Channel
10. Middle East and Africa Post-traumatic Stress Disorder Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Distribution Channel
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Post-traumatic Stress Disorder Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Distribution Channel
10.3.2. Saudi Arabia Post-traumatic Stress Disorder Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Distribution Channel
10.3.3. South Africa Post-traumatic Stress Disorder Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (As Reported)
13.5. Recent Developments
13.5.1. Lupin Limited
13.5.1.1. Business Overview
13.5.1.2. Company Snapshot
13.5.1.3. Products & Services
13.5.1.4. Financials (As Reported)
13.5.1.5. Recent Developments
13.5.2. Pfizer Inc.
13.5.2.1. Business Overview
13.5.2.2. Company Snapshot
13.5.2.3. Products & Services
13.5.2.4. Financials (As Reported)
13.5.2.5. Recent Developments
13.5.3. Aurobindo Pharma Limited
13.5.3.1. Business Overview
13.5.3.2. Company Snapshot
13.5.3.3. Products & Services
13.5.3.4. Financials (As Reported)
13.5.3.5. Recent Developments
13.5.4. Merck KGaA
13.5.4.1. Business Overview
13.5.4.2. Company Snapshot
13.5.4.3. Products & Services
13.5.4.4. Financials (As Reported)
13.5.4.5. Recent Developments
13.5.5. GlaxoSmithKline plc.
13.5.5.1. Business Overview
13.5.5.2. Company Snapshot
13.5.5.3. Products & Services
13.5.5.4. Financials (As Reported)
13.5.5.5. Recent Developments
13.5.6. Otsuka Pharmaceutical Development & Commercialization, Inc.
13.5.6.1. Business Overview
13.5.6.2. Company Snapshot
13.5.6.3. Products & Services
13.5.6.4. Financials (As Reported)
13.5.6.5. Recent Developments
13.5.7. Jazz Pharmaceuticals Inc.
13.5.7.1. Business Overview
13.5.7.2. Company Snapshot
13.5.7.3. Products & Services
13.5.7.4. Financials (As Reported)
13.5.7.5. Recent Developments
13.5.8. Bionomics Ltd.
13.5.8.1. Business Overview
13.5.8.2. Company Snapshot
13.5.8.3. Products & Services
13.5.8.4. Financials (As Reported)
13.5.8.5. Recent Developments
13.5.9. Aptinyx Inc.
13.5.9.1. Business Overview
13.5.9.2. Company Snapshot
13.5.9.3. Products & Services
13.5.9.4. Financials (As Reported)
13.5.9.5. Recent Developments
13.5.10. AstraZeneca Plc
13.5.10.1. Business Overview
13.5.10.2. Company Snapshot
13.5.10.3. Products & Services
13.5.10.4. Financials (As Reported)
13.5.10.5. Recent Developments
14. Strategic Recommendations